ARCL Organics Ltd (ARCL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by ARCL Organics Ltd on NSE and BSE, with an AI summary of each filing.
Receipt of Order by DRT-I of Kolkata
Others (Uncategorized) · 07 Oct 2026, 11:21 pm
ARCL Organics Settles SASF Dispute via DRT Order, Unencumbering Core Manufacturing Asset ARCL Organics received a final order dated 6th Oct'26 from DRT-I, Kolkata, disposing of the recovery application (OA/86/2005) filed by Stressed Assets Stabilisation Fund (SASF). The tribunal confirmed the settlement with payments of ₹8.23 cr towards principal and ₹21.95 lakh towards interest, leaving no further financial liability. Consequently, the company is entitled to an NOC and the release of charges/encumbrances over its primary land and manufacturing facility at Rampur upon completing standard documentation formalities.
ARCL Organics Ltd has informed the exchange about receipt of show cause notice dated 30.09.2026.
Others (Uncategorized) · 01 Oct 2026, 8:37 pm
ARCL Organics Receives ₹5.05 Crore GST Show Cause Notice for FY23 ARCL Organics Limited received a Show Cause Notice on 30th Sep'26 from the West Bengal GST Authority proposing a total demand of ₹5.05 crore for FY23. The claim includes tax of ₹2.78 crore, interest of ₹2.00 crore, and a penalty of ₹0.28 crore under Section 73 of the GST Acts. The dispute stems from the classification of "Aqua Strong Bond" under HSN 3906 versus HSN 2309. The company disputes the claim, stating no immediate operational or financial impact, and will proceed via legal routes.
Please find attached voting result of the 34th Annual General Meeting of the Company along with Scrutinizer''s Report.
Annual General Meeting · 21 Sept 2026, 9:33 pm
Proceedings of the 34th Annual General Meeting of ARCL Organics Limited held on 19th September 2026
Annual General Meeting · 20 Sept 2026, 2:48 am
Please find attached Scrutinizer''s Report of 34th AGM of the Company.
Annual General Meeting · 20 Sept 2026, 1:58 am
Please find attached outocme of 34th AGM and Scrutinizer''s Report
Annual General Meeting · 20 Sept 2026, 1:53 am
Appointment of Mr. Deepak Daga as a Company Secretary and Compliance officer of the Company with effect from 16.09.2026
Change in Management · 16 Sept 2026, 4:37 pm
ARCL Organics Appoints Deepak Daga as Company Secretary and Compliance Officer ARCL Organics Limited announced that its Board of Directors approved the appointment of Mr. Deepak Daga (ACS: 50346) as Company Secretary and Compliance Officer, effective 16th Sep'26. The appointment was made upon the recommendation of the Nomination & Remuneration Committee to comply with Section 203 of the Companies Act, 2013, and Regulation 6 of SEBI LODR Regulations. Mr. Daga, an Associate Member of the ICSI, holds no equity shares in the company and has no relationship with any board directors.
Appointment of Mr. Deepak Daga as a Company Secretary and Compliance Officer of the Company with effect from 16.09.2026
Change in Management · 16 Sept 2026, 4:34 pm
ARCL Organics Appoints Deepak Daga as Company Secretary and Compliance Officer The Board of Directors of ARCL Organics Limited, based on the recommendation of the Nomination & Remuneration Committee, approved the appointment of Mr. Deepak Daga (Membership No. ACS 50346) as Company Secretary and Compliance Officer, effective 16th Sep'26. The appointment fulfills statutory requirements under Section 203 of the Companies Act, 2013, and Regulation 6 of SEBI LODR Regulations, 2015. Mr. Daga holds no equity shares in the company and is unrelated to any member of the Board of Directors.
Outcome of Board Meeting held as on Today i.e. 16.09.2026 held for the Appointment of Company Secretary.
Others (Uncategorized) · 16 Sept 2026, 4:26 pm
ARCL Organics Appoints Deepak Daga as Company Secretary and Compliance Officer The Board of Directors of ARCL Organics Limited, at its meeting held on 16th Sep'26, approved the appointment of Mr. Deepak Daga (ACS: 50346) as Company Secretary and Compliance Officer, effective 16th Sep'26. The appointment follows the recommendation of the Nomination & Remuneration Committee to ensure statutory compliance under Section 203 of the Companies Act, 2013, and Regulation 6 of SEBI LODR. Mr. Daga holds no equity shares in the company and has no familial relationships with any existing directors.
Please find letter to shareholders containing weblink for accessing Annual Report of 2025-2026
Annual General Meeting · 16 Sept 2026, 12:36 am
Enclosed herewith Revised ''Annual Report for Financial Year 2025-2026'' of ARCL Organics Limited.
Others (Uncategorized) · 16 Sept 2026, 12:21 am
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, this is to inform you that the National Stock Exchange of India Limited (NSE), ....
Others (Uncategorized) · 11 Sept 2026, 12:17 am
ARCL Organics Equity Shares Admitted Under NSE Permitted to Trade Category ARCL Organics Limited announced that the National Stock Exchange of India (NSE), via circular dated 14th Aug'26, admitted its equity shares (Symbol: ARCL; ISIN: INE372M01010) to dealings in the Capital Market segment, effective 17th Aug'26. The company clarified that its equity shares remain listed exclusively on BSE Limited and are made available on NSE under the "Permitted to Trade" (PTT) category pursuant to applicable regulatory provisions, encompassing 8,000,000 equity shares with a face value of Rs 10 each in market lots of one.
Corrigendum to the notice of 34th Annual General Meeting of the Company.
Annual General Meeting · 05 Sept 2026, 12:36 am
Arcl Organics Limited has informed the exchange regarding the name change of subsidiary company pursuant to Regulation 30 of SEBI (LODR) Regulation, 2015.
Others (Uncategorized) · 04 Sept 2026, 11:18 pm
ARCL Organics Renames Subsidiary to Arcl Lifesciences Private Limited ARCL Organics Limited announced on 4th Sep'26 that its subsidiary company, Suksess Chemicals Private Limited, has officially changed its name to Arcl Lifesciences Private Limited. The regulatory intimation was submitted pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015.
Please find enclosed a copy of Annual Report of the Company for the financial year 2025-26.
Others (Uncategorized) · 29 Aug 2026, 5:14 am
Please find enclosed notice of 34th Annual General Meeting of the members of the company scheduled to be held on Saturday 19th September 2026 at 03.30 P.M (IST) through (VC/OAVM)
Annual General Meeting · 29 Aug 2026, 5:04 am
With reference to the captioned subject, this is to inform comments made by the Board of Directors of the Company.
Others (Uncategorized) · 13 Aug 2026, 9:07 pm
ARCL Organics Fined for Compliance Breach ARCL Organics was fined Rs. 5,900 by the BSE for delayed submission of related party transaction disclosures for the half-year ended 31st Mar'26. The company attributed the delay to a technical glitch and paid the fine on 3rd Jul'26. The Board of Directors acknowledged the lapse at its meeting on 12th Aug'26 and has committed to ensuring timely compliance in the future. The penalty, while minor, highlights a procedural non-compliance with SEBI Listing Regulations.
Unaudited Financial Results And Limited Review Report for the quarter ended on 30th June 2026
Financial Result · 12 Aug 2026, 7:49 pm
ARCL Organics Posts Strong Q1 FY27 Results; Board Approves AGM Details ARCL Organics reported robust Q1 FY27 consolidated results with Net Profit After Tax at ₹911.90 lakhs, up 128.4% YoY. Revenue from operations stood at ₹6,694.78 lakhs, a slight YoY decline. EBITDA grew 127% YoY to ₹1,656.25 lakhs. The board, meeting on 12th Aug'26, approved the 34th AGM for 19th Sep'26. E-voting is scheduled from 16th Sep'26 to 18th Sep'26. Book closure dates are set from 12th Sep'26 to 19th Sep'26 for the purpose of the AGM.
Unaudited Financial Results and Limited Review Report for the quarter ended on 30th June 2026
Outcome · 12 Aug 2026, 7:38 pm
ARCL Organics Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 6,695 (-0.6% YoY | +2.5% QoQ) ■ EBITDA: 1,563 (+141.8% YoY | +120.6% QoQ) ■ EBITDA Margin (%): 23.3 (+1375 bps YoY | +1250 bps QoQ) ■ PAT: 912 (+128.4% YoY | +226.9% QoQ) ■ EPS (INR): 11.4 (+128.5% YoY | +226.6% QoQ)
ARCL Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve ARCL Organics Ltd has informed ....
Intimation · 12 Aug 2026, 5:30 am
ARCL Organics to Announce Q1 FY27 Results on 12th Aug'26 ARCL Organics has scheduled a Board of Directors meeting for 12th Aug'26 to consider and approve the unaudited standalone and consolidated financial results for the first quarter ended 30th Jun'26. The meeting will also review the Independent Auditor's Limited Review Report for the same period. In line with regulations, the trading window for designated persons is closed and will reopen 48 hours after the results are publicly announced.
Pursuant to Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued ....
Others (Uncategorized) · 01 Jul 2026, 6:10 pm
ARCL Fined by BSE for Late Disclosure Filing ARCL Organics received a fine of Rs. 5,900 from the BSE on 30th Jun'26 for a one-day delay in submitting disclosures on related party transactions, violating Regulation 23(9) of SEBI Listing Regulations. The company stated the financial impact is limited to the penalty amount. This regulatory action highlights a minor compliance lapse.
Appointment of M/s AMIT KHETAN & Co. As Cost Auditor For Financial Year 2026-27
Change in Auditor · 18 May 2026, 6:38 pm
ARCL Appoints Cost Auditor for FY27; Discloses Appointment with Delay ARCL Organics appointed AMIT KHETAN & CO. (FRN 102559) as its Cost Auditor for the financial year 2026-2027. The appointment was approved by the Board of Directors on 07th May'26. The company disclosed this information to the exchange on 18th May'26, citing an inadvertent oversight and administrative omission for the delay in submission beyond the prescribed timeline under SEBI Listing Regulations. The appointment fulfills regulatory requirements under the Companies Act, 2013 and SEBI rules.
Appointment of M/s MIB & Co. As Internal Auditor For FInancial Year 2026-27
Change in Auditor · 18 May 2026, 6:32 pm
ARCL Organics Reappoints Internal Auditor for FY27, Discloses with Delay ARCL Organics Limited announced a delayed disclosure regarding the reappointment of its internal auditor. At a Board Meeting on 07th May'26, the company reappointed MIB & Co., Chartered Accountants (FRN 329273E) to serve as its Internal Auditor for the financial year 2026-2027. The company attributed the delay in notifying the stock exchange to an "inadvertent oversight and administrative omission." MIB & Co. has over 15 years of experience in audit, tax, and advisory services.
Audited Financial Results For the Financial Year ended on 31st March 2026
Financial Result · 08 May 2026, 12:29 am
ARCL ORGANICS LTD - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 6531 (-9.6% YoY | +22.2% QoQ) ■ EBITDA: 709 (-20.8% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 10.9 (-153 bps YoY | Loss to Profit QoQ) ■ PAT: 279 (-50.2% YoY | Loss to Profit QoQ) ■ EPS (INR): 3.49 (-50.1% YoY | Loss to Profit QoQ)
Audited Financial Results for the financial year ended on 31st March 2026
Outcome · 07 May 2026, 11:26 pm
ARCL ORGANICS LTD - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 6531 (-9.6% YoY | +22.2% QoQ) ■ EBITDA: 709 (-20.8% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 10.9 (-153 bps YoY | Loss to Profit QoQ) ■ PAT: 279 (-50.2% YoY | Loss to Profit QoQ) ■ EPS (INR): 3.49 (-50.1% YoY | Loss to Profit QoQ)